drugset / Trial / NCT01245543
Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
AC480IV will be administered as a monotherapy and then in combination with docetaxel in patients with locally advanced or metastatic solid tumors for whom there are no standard or curative therapies available. It is designed to evaluate the safety and pharmacokinetic parameters of AC480IV as monotherapy and also in combination with docetaxel under the conditions of the study.
Timeline
- Start
- 2010-11
- Primary completion
- 2013-03
- Completion
- 2013-06
Outcome
Outcome not reported
Stopped: “Clinical investigations have been discontinued and transfer to BMS 3/24/2015”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AC480 | Small molecule | — | Intravenous |
| Background | Docetaxel | Small molecule | — | Intravenous |